Nomic Bio has developed the nELISA platform, a groundbreaking technology that enhances traditional ELISA methods to enable high-throughput proteomics. This innovative approach utilizes DNA nanotechnology to achieve true multiplexing, allowing for the simultaneous profiling of a vast array of proteins without the common issues of cross-reactivity. The nELISA platform is designed to handle over 10,000 samples per week, making it a highly efficient solution for protein profiling. It offers flexibility in selecting proteins, allowing researchers to customize their panels, and provides quantitative profiling with exceptional precision, all while maintaining cost-effectiveness.

The nELISA technology incorporates several advanced strategies, including colocalization and proximity-based multiplexing, to ensure accurate and reliable results. By using universal DNA structures to pre-assemble antibody pairs, the platform effectively prevents cross-reactivity from occurring, thus enhancing the quality of the data generated. Nomic Bio's commitment to expanding access to the proteome is further demonstrated through collaborations, such as the partnership with the Parker Institute for Cancer Immunotherapy, which aims to investigate immunotherapy responses by quantifying circulating protein markers in patient samples. This positions Nomic Bio as a leader in the field of protein profiling, significantly advancing research capabilities in immunology and drug discovery.

Canada

Nomic (formerly nplex biosciences) is a bioengineering company working to make the human proteome as broadly and easily accessible as the human genome. We are building the nELISA, a next-generation ELISA platform for measuring proteins at scale and at high throughput. The nELISA was designed to seamlessly integrate into current workflows in biology and is uniquely adaptable to a wide variety of use cases within drug and biomarker development workflows. Nomic is headquartered in Montreal, with labs and offices in Boston. For more information, visit www.nomic.bio.

Nomic Bio

Company Details